WebPlatinum-based agents are important drugs or drug candidates for cancer chemotherapy. Traditional platinum drugs including the globally approved cisplatin, carboplatin and … Web22 apr. 2024 · that they might be more sensitive to platinum damage. Based on this biological rationale, several studies have evaluated the impact of adding platinum-based agents to standard chemotherapy; however, the results are con-flicting.8–10 Meanwhile, current recommenda-tions in several international breast cancer guidelines are also …
Platinum chemotherapy - University of Nottingham
Web5 okt. 2024 · Out of 42 patients diagnosed with advanced non-resectable NSCLC who were treated with platinum-based chemotherapy or had symptoms treated, we extracted 42 cases with complete follow up. This included 17 individuals who received symptoms treatment only (natural history, NH, cohort) and 25 patients who underwent platinum … WebChemotherapeutic agents, also referred to as antineoplastic agents, are used to directly or indirectly inhibit the uncontrolled growth and proliferation of cancer cells. They are classified according to their mechanism of action and include. alkylating agents. , antimetabolites. , topoisomerase inhibitors. , antibiotics, mitotic inhibitors, and. church ruins of bancuro
Uptake of Maintenance Immunotherapy and Changes in Upstream …
Web15 mrt. 2024 · Key Points. Question How many cancer therapies approved by the US Food and Drug Administration between 2016 and 2024 displaced standard-of-care therapies vs being added to existing therapies in the metastatic, adjuvant, and maintenance settings?. Findings In this cross-sectional study, between May 1, 2016, and May 31, 2024, there … Web13 apr. 2024 · Eighty-nine percent of patients previously received androgen-signaling inhibitor(s), 68% had platinum-based chemotherapy, and 50% had prior taxane chemotherapy. The median duration of follow-up was 30.8 weeks (range, 1.9-86.9), and the median duration of treatment was 9 weeks (range, 0.7-63). Web20 mei 2008 · 19088 Background: Single-agent chemotherapy as a first-line treatment is currently considered as the standard approach for elderly patients with advanced NSCLC. Since the platinum-based combination chemotherapy is the standard treatment for younger patients with advanced NSCLC, it may also have more effective for elderly. We … church ruins in south carolina